<DOC>
	<DOCNO>NCT01179620</DOCNO>
	<brief_summary>This study ass efficacy , safety pharmacokinetics certoparin use prevent clot hemodialysis .</brief_summary>
	<brief_title>Certoparin Renal Patients Undergoing Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Certoparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>Patients require hemodialysis Patients require anticoagulation therapy hemodialysis Written inform consent Hypersensitivity study medication Genetic abnormality disease clot system Prior major surgery bleed Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Hemodialysis , Certoparin</keyword>
</DOC>